annual CFF:
$353.37M+$89.23M(+33.78%)Summary
- As of today (September 16, 2025), SNDX annual cash flow from financing activities is $353.37 million, with the most recent change of +$89.23 million (+33.78%) on December 31, 2024.
- During the last 3 years, SNDX annual CFF has risen by +$234.90 million (+198.29%).
- SNDX annual CFF is now at all-time high.
Performance
SNDX Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$551.00K-$379.00K(-40.75%)Summary
- As of today (September 16, 2025), SNDX quarterly cash flow from financing activities is $551.00 thousand, with the most recent change of -$379.00 thousand (-40.75%) on June 30, 2025.
- Over the past year, SNDX quarterly CFF has dropped by -$125.00 thousand (-18.49%).
- SNDX quarterly CFF is now -99.84% below its all-time high of $347.43 million, reached on December 31, 2024.
Performance
SNDX quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$352.00M-$125.00K(-0.04%)Summary
- As of today (September 16, 2025), SNDX TTM cash flow from financing activities is $352.00 million, with the most recent change of -$125.00 thousand (-0.04%) on June 30, 2025.
- Over the past year, SNDX TTM CFF has increased by +$88.83 million (+33.75%).
- SNDX TTM CFF is now -0.39% below its all-time high of $353.37 million, reached on December 31, 2024.
Performance
SNDX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
SNDX Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +33.8% | -18.5% | +33.8% |
| 3 y3 years | +198.3% | -97.5% | +163.2% |
| 5 y5 years | +1136.8% | -99.5% | +114.5% |
SNDX Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +198.3% | -99.8% | +104.1% | -0.4% | +197.0% |
| 5 y | 5-year | at high | +1136.8% | -99.8% | +104.1% | -0.4% | +198.2% |
| alltime | all time | at high | +6089.6% | -99.8% | +104.1% | -0.4% | >+9999.0% |
SNDX Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $551.00K(-40.8%) | $352.00M(-0.0%) |
| Mar 2025 | - | $930.00K(-99.7%) | $352.13M(-0.4%) |
| Dec 2024 | $353.37M(+33.8%) | $347.43M(>+9900.0%) | $353.37M(+33.6%) |
| Sep 2024 | - | $3.10M(+358.3%) | $264.43M(+0.5%) |
| Jun 2024 | - | $676.00K(-68.8%) | $263.18M(-0.2%) |
| Mar 2024 | - | $2.17M(-99.2%) | $263.83M(-0.1%) |
| Dec 2023 | $264.13M(+53.3%) | $258.48M(>+9900.0%) | $264.13M(+56.2%) |
| Sep 2023 | - | $1.85M(+39.8%) | $169.15M(+10.0%) |
| Jun 2023 | - | $1.32M(-46.5%) | $153.78M(-11.7%) |
| Mar 2023 | - | $2.47M(-98.5%) | $174.17M(+1.1%) |
| Dec 2022 | $172.25M(+45.4%) | $163.50M(-1308.9%) | $172.25M(+45.3%) |
| Sep 2022 | - | -$13.53M(-162.3%) | $118.53M(-11.4%) |
| Jun 2022 | - | $21.72M(+3799.5%) | $133.76M(+13.3%) |
| Mar 2022 | - | $557.00K(-99.5%) | $118.06M(-0.3%) |
| Dec 2021 | $118.46M(-61.1%) | $109.78M(+6338.7%) | $118.46M(-19.6%) |
| Sep 2021 | - | $1.71M(-71.7%) | $147.34M(-0.0%) |
| Jun 2021 | - | $6.02M(+527.1%) | $147.41M(-41.1%) |
| Mar 2021 | - | $960.00K(-99.3%) | $250.39M(-17.8%) |
| Dec 2020 | $304.42M(+965.5%) | $138.66M(+7747.1%) | $304.42M(+83.6%) |
| Sep 2020 | - | $1.77M(-98.4%) | $165.82M(+1.0%) |
| Jun 2020 | - | $109.00M(+98.2%) | $164.14M(+197.7%) |
| Mar 2020 | - | $55.00M(>+9900.0%) | $55.14M(+93.0%) |
| Dec 2019 | $28.57M | $58.00K(-27.5%) | $28.57M(-17.6%) |
| Sep 2019 | - | $80.00K(+1233.3%) | $34.66M(-21.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | $6000.00(-100.0%) | $44.04M(-0.2%) |
| Mar 2019 | - | $28.43M(+362.6%) | $44.12M(+180.5%) |
| Dec 2018 | $15.73M(-79.2%) | $6.14M(-35.1%) | $15.73M(-55.3%) |
| Sep 2018 | - | $9.46M(>+9900.0%) | $35.20M(+31.6%) |
| Jun 2018 | - | $89.00K(+169.7%) | $26.74M(-64.6%) |
| Mar 2018 | - | $33.00K(-99.9%) | $75.64M(-0.1%) |
| Dec 2017 | $75.72M(+39.7%) | $25.61M(+2451.2%) | $75.72M(+50.6%) |
| Sep 2017 | - | $1.00M(-98.0%) | $50.28M(-1.4%) |
| Jun 2017 | - | $48.99M(>+9900.0%) | $50.99M(+6513.5%) |
| Mar 2017 | - | $117.00K(-33.5%) | $771.00K(-98.6%) |
| Dec 2016 | $54.20M(-29.9%) | $176.00K(-89.7%) | $54.20M(+0.3%) |
| Sep 2016 | - | $1.71M(-238.8%) | $54.03M(+3.3%) |
| Jun 2016 | - | -$1.23M(-102.3%) | $52.32M(-2.3%) |
| Mar 2016 | - | $53.55M(+463.0%) | $53.55M(+163.9%) |
| Dec 2015 | $77.27M(+522.6%) | - | - |
| Dec 2014 | $12.41M(-40.6%) | - | - |
| Sep 2014 | - | $9.51M(-1166.3%) | $20.29M(+17.6%) |
| Jun 2014 | - | -$892.00K(+337.3%) | $17.25M(-4.9%) |
| Mar 2014 | - | -$204.00K(-101.7%) | $18.15M(-8.7%) |
| Dec 2013 | $20.89M(+265.9%) | $11.88M(+83.4%) | $19.88M(+148.3%) |
| Sep 2013 | - | $6.47M(+322.1%) | $8.01M(+422.1%) |
| Mar 2013 | - | $1.53M | $1.53M |
| Dec 2012 | $5.71M(-33.8%) | - | - |
| Dec 2011 | $8.63M | - | - |
FAQ
- What is Syndax Pharmaceuticals, Inc. annual cash flow from financing activities?
- What is the all time high annual CFF for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. annual CFF year-on-year change?
- What is Syndax Pharmaceuticals, Inc. quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. quarterly CFF year-on-year change?
- What is Syndax Pharmaceuticals, Inc. TTM cash flow from financing activities?
- What is the all time high TTM CFF for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. TTM CFF year-on-year change?
What is Syndax Pharmaceuticals, Inc. annual cash flow from financing activities?
The current annual CFF of SNDX is $353.37M
What is the all time high annual CFF for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high annual cash flow from financing activities is $353.37M
What is Syndax Pharmaceuticals, Inc. annual CFF year-on-year change?
Over the past year, SNDX annual cash flow from financing activities has changed by +$89.23M (+33.78%)
What is Syndax Pharmaceuticals, Inc. quarterly cash flow from financing activities?
The current quarterly CFF of SNDX is $551.00K
What is the all time high quarterly CFF for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high quarterly cash flow from financing activities is $347.43M
What is Syndax Pharmaceuticals, Inc. quarterly CFF year-on-year change?
Over the past year, SNDX quarterly cash flow from financing activities has changed by -$125.00K (-18.49%)
What is Syndax Pharmaceuticals, Inc. TTM cash flow from financing activities?
The current TTM CFF of SNDX is $352.00M
What is the all time high TTM CFF for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high TTM cash flow from financing activities is $353.37M
What is Syndax Pharmaceuticals, Inc. TTM CFF year-on-year change?
Over the past year, SNDX TTM cash flow from financing activities has changed by +$88.83M (+33.75%)